Gastrointestinal growth factors and hormones have divergent effects on Akt activation

作者: Marc J. Berna , Jose A. Tapia , Veronica Sancho , Michelle Thill , Andrea Pace

DOI: 10.1016/J.CELLSIG.2009.01.003

关键词: Protein kinase CProtein kinase BInternal medicineBiologyEndocrinologySignal transductionPhospholipase CPhosphorylationProtein tyrosine phosphatasePI3K/AKT/mTOR pathwayKinaseCell biology

摘要: Akt is a central regulator of apoptosis, cell growth and survival. Growth factors some G-protein-coupled receptors (GPCR) regulate Akt. Whereas growth-factor activation has been extensively studied, the regulation by GPCR's, especially gastrointestinal hormones/neurotransmitters, remains unclear. To address this area, in study effects GI hormones/neurotransmitters were investigated rat pancreatic acinar cells which are high responsive to these agents. Pancreatic acini expressed 5 7 known growth-factors stimulate phosphorylation (T308, S473) translocation. These mediated p85 PI3K. hormones increasing intracellular cAMP had similar effects. However, GI-hormones/neurotransmitters [CCK, bombesin, carbachol] activating phospholipase C (PLC) inhibited basal growth-factor-stimulated activation. Detailed studies with CCK, both physiological pathophysiological on at different concentrations, demonstrated CCK biphasic effect: low concentrations (pM) stimulating Src-dependent mechanism higher (nM) stimulated translocation, activation, de-phosphorylating resulting decreasing PI3K activity. This effect required limbs PLC-pathway protein tyrosine phosphatase, but was not p44/42 MAPK, Src or serine phosphatase. inhibition also found vivo Panc-1 cancer where it serum-mediated rescue from apoptosis. results demonstrate that as well cellular basis action can all cells. complex agents such because stimulatory inhibitory be seen, mechanisms.

参考文章(121)
Morisset J, Intervention of GI neuropeptides in pancreatic growth and regeneration: comparison with cholecystokinin. Journal of Physiology and Pharmacology. ,vol. 54, pp. 127- 141 ,(2003)
S J Pandol, R T Jensen, J D Gardner, Mechanism of [Tyr4]bombesin-induced desensitization in dispersed acini from guinea pig pancreas. Journal of Biological Chemistry. ,vol. 257, pp. 12024- 12029 ,(1982) , 10.1016/S0021-9258(18)33671-8
Markus W. Büchler, Munehiro Yokoyama, Helmut Friess, Matthias Ebert, Murray Korc, Coexpression of the c-met Proto-oncogene and Hepatocyte Growth Factor in Human Pancreatic Cancer Cancer Research. ,vol. 54, pp. 5775- 5778 ,(1994)
Shigetoshi Yano, Hiroshi Tokumitsu, Thomas R. Soderling, Calcium promotes cell survival through CaM-K kinase activation of the protein-kinase-B pathway Nature. ,vol. 396, pp. 584- 587 ,(1998) , 10.1038/25147
H. Hayashi, Y. Nishioka, S. Kamohara, F. Kanai, K. Ishii, Y. Fukui, F. Shibasaki, T. Takenawa, H. Kido, N. Katsunuma, The alpha-type 85-kDa subunit of phosphatidylinositol 3-kinase is phosphorylated at tyrosines 368, 580, and 607 by the insulin receptor. Journal of Biological Chemistry. ,vol. 268, pp. 7107- 7117 ,(1993) , 10.1016/S0021-9258(18)53152-5
C.J. Vlahos, W.F. Matter, K.Y. Hui, R.F. Brown, A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). Journal of Biological Chemistry. ,vol. 269, pp. 5241- 5248 ,(1994) , 10.1016/S0021-9258(17)37680-9
Bridget N Fahy, Michael G Schlieman, Subbulakshmi Virudachalam, Richard J Bold, Inhibition of AKT abrogates chemotherapy- induced NF-κB survival mechanisms: implications for therapy in pancreatic cancer Journal of The American College of Surgeons. ,vol. 198, pp. 591- 599 ,(2004) , 10.1016/J.JAMCOLLSURG.2003.12.005
M Spanarkel, J Martinez, C Briet, R T Jensen, J D Gardner, Cholecystokinin-27-32-amide. A member of a new class of cholecystokinin receptor antagonists. Journal of Biological Chemistry. ,vol. 258, pp. 6746- 6749 ,(1983) , 10.1016/S0021-9258(18)32283-X